Author:
Tirmenstein Mark,Peri Ravikumar
Publisher
Springer Nature Singapore
Reference17 articles.
1. Weisburger J, Weisburger E (1967) Tests for animal carcinogens. Methods Cancer Res 1:307–398
2. Jacobs AC, Hatfield KP (2013) History of chronic toxicity and animal carcinogenicity studies for pharmaceuticals. Vet Pathol 50:324–333
3. Bogdanffy MS, Lesniak J, Mangipudy R, Sistare FD, Colman K, Garcia-Tapia D, Monticello T, Blanset D (2020) Tg.rasH2 mouse model for assessing carcinogenic potential of pharmaceuticals: industry survey of current practices. Int J Toxicol 39:198–206
4. ICH guideline: preclinical safety evaluation of biotechnology-derived pharmaceuticals S6(R1). https://www.ich.org/page/safety-guidelines. Accessed 10 Aug 2022
5. Cohen SM, Klaunig J, Meek ME, Hill RN, Pastoor T, Lehman-McKeeman L, Bucher J, Longfellow DG, Seed J, Dellarco V, Fenner-Crisp P, Patton D (2004) Evaluating the human relevance of chemically induced animal tumors. Toxicol Sci 78:181–186